The global polypeptide market is entering an era of accelerated capital investment, driven by the expanding therapeutic applications of custom and bioactive polypeptide sequences across metabolic, oncology, and cardiovascular fields. Global biopharmaceutical innovators, contract development and manufacturing organizations (CDMOs), and macromolecular clinical research hubs are aggressively...